820232-50-6

• 常用中文名：Pasireotide diaspartate
• 常用英文名：Pasireotide diaspartate
• CAS号：820232-50-6
• 分子式：C₆₆H₈₀N₁₂O₁₇
• 分子量：1313.412
• 发布时间：2021-01-08 09:53:04
• 更新时间：2024-01-09 12:07:58
• Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

名称

• 英文名: Pasireotide diaspartate
• 英文别名: I4P76SY3N4; L-Aspartic acid, compd. with cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl] (2:1); pasireotide aspartate; Pasireotide diaspartate; L-Aspartic acid - cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl] (2:1); Signifor

物化性质

• 分子式: C₆₆H₈₀N₁₂O₁₇
• 分子量: 1313.412
• 精确质量: 1312.576416